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INTRODUCTION
Mushrooms are the main reason for hospital-
ization due to plant and fungi poisonings in Bulgar-
ia. In Turkey the main portion of such toxicities com-
prises mushroom poisoning (1). The most impor-
tant mushroom poisonings for toxicological prac-
tice in Southeast Europe are those with A. phalloides 
mushrooms. A. phalloides poisonings are a world-
wide problem. Most reported A. phalloides poison-
ings occur in Europe (2). Approximately 50-100 fa-
tal cases are reported every year in Western Europe 
with them being less common in the United States. 
Cases of amatoxin poisoning from Africa, Asia, Aus-
tralia and Central and South America have also been 
reported (3,4). Mushroom poisoning by A. phalloi-
des is a rare but potentially fatal condition (5). Poi-
soning with Death cap (Amanita phalloides (Vaill. 
ex Fr.) Link) is a serious medical condition, causing 
organ failure with potential fatal outcome (6). Death 
cap is a toxic mushroom responsible for the major-
ity of deaths occurring after mushrooms ingestion 
(2,7). A. phalloides is the most dangerous, poisonous 
mushroom species. It has been involved in the ma-
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jority of human deaths from mushroom poisoning 
(90-95%) (3,8).
In this regard, we aimed to examine the A. phal-
loides poisonings in Varna region for a period of 25 
years - from 1991 to 2015, analysing their frequency, 
distribution by sex and age, clinical course and ther-
apeutic behaviour and lethality.
MATERIALS AND METHODS
The objects of the study were 147 patients treat-
ed at the Clinic of Toxicology of Military hospital 
Varna, the only Clinic of Toxicology in the Eastern 
Bulgaria, for a period of 25 years. The study was ret-
rospective. The disease history, personal medical re-
cords of the admitted for treatment patients and med-
ico-legal protocols from autopsies of the deceased pa-
tients were analysed. The diagnosis was based on:
 a history of consumption of wild mushrooms
 prolonged latent period of more than six hours
 severe gastrointestinal syndrome with repeated 
vomiting and watery diarrhoea stools
 expressed astheno-adynamic syndrome
 abnormal liver tests
We did not use radio-immunological or 
chromatographic determination of fungal toxins in 
serum and urine. The diagnosis was based on the 
combination of those clinical criteria.
RESULTS AND DISCUSSION
During the analysed period, 147 patients with 
A. phalloides poisoning have received treatment. 
Their relative share to all patients with acute intoxi-
cation is low - 0.8% confirming the low frequency of 
A. phalloides poisoning. In the neighbouring Turkey 
a significantly higher frequency with relative share 
of about 3% was reported (9). All A. phalloides poi-
sonings result from consumption of wild Death cap 
mushrooms instead of edible mushrooms. The tox-
icity of A. phalloides is due to two groups of toxins 
- phallotoxins and amatoxins. Phallotoxins damage 
the cell membrane of enterocytes and cause gastroin-
testinal symptoms, such as nausea, vomiting, and di-
arrhoea. They are not absorbed by the intestine and 
do not reach the liver (10). Amatoxins are bicyclic oc-
tapeptides and are potentially lethal substances (11, 
12). Amatoxins - alpha-, beta- and gamma-Amanitin 
are resistant to high temperatures with alpha-Am-
anitin having the highest toxicity (1,10,13,14). They 
are not destroyed by cooking and can be present after 
long periods of storage (13,15). Amatoxins are easily 
absorbed through the intestinal epithelial cells and 
quickly leave the plasma because of a weak binding 
to plasma proteins up to the 48th hour after ingest-
ing A. phalloides mushrooms, but are included in the 
enterohepatic circulation up to the 4th day (16,17). 
About 60% of alpha-Amanitin is excreted in bile and 
included in the enterohepatic circulation, which ex-
tends its effect to the liver cells (18). In addition to 
hepatotoxicity amatoxin possesses nephrotoxicity, 
damaging the proximal and distal tubules (19). In-
testinal mucosa, hepatocytes and proximal tubules of 
the kidney are the main target structures, which are 
damaged by the toxins of A. phalloides mushrooms 
(4,11,16,20,21). Amatoxins directly interact with the 
enzyme RNA polymerase II in eukaryotic cells, in-
hibit transcription, prevent protein synthesis and 
cause cell death (16,22). The lethal amatoxin dose 
for humans is 0.1 mg/kg body weight (8) and may be 
contained in one single mushroom (16,22). The con-
sumption of about 50 g fresh mushroom may be le-
thal (12).
Most of the patients who received treatment 
were men - 91 (61.9%). Women were 56 (38.1%) and 
the ratio of men to women was 1.62:1. The average 
age of patients with A. phalloides poisoning was 52.5 
years (16-86). The analysis of the distribution of A. 
phalloides intoxications by age indicated that the 
most affected age group was from 45 to 60 years - 62 
cases (42.2%) and their frequency in patients up to 24 
years was very low (4.1%) - Table. 1.
A. phalloides poisonings in Bulgaria are most 
common in late summer and autumn, as in the 
period from August to November 136 cases (92.5%) 
were registered. The peak of intoxication was in 
October, when more than half of the poisonings were 
registered (Table. 2).
Age Number of patients Percent 
up to 24 6 4.1
25 - 44 35 23.8
45 - 60 62 42.2
above 60 44 29.9
Table 1. Distribution of A. phalloides intoxication by age
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The clinical picture of A. phalloides intoxication 
can be viewed in four phases.
1. Asymptomatic lag phase - from the time of 
ingestion of mushrooms to the appearance of 
the first symptoms. It continues from 6 to 24 
hours (18,22), while according to other authors, 
duration can reach 40 hours (16) and most often 
lasts 10-12 hours (13,16,22,23). The average 
duration of the latency period in our study was 
11 hours (7-20).
2. Gastrointestinal phase - characterised by the 
appearance of nausea, abdominal pain, repeat-
ed vomiting and watery diarrhoea stools, caus-
ing dehydration, arterial hypotension and elec-
trolyte abnormalities. It lasts for about 12-24 
hours. During this phase serum transaminas-
es are already abnormal.
3. Apparent convalescence - develops 36-48 hours 
after ingestion of mushrooms. Gastrointestinal 
symptoms diminish or disappear, but serum 
transaminases continued to increase and jaun-
dice may occur.
4. Acute liver failure - characterised by a pro-
longed increase in transaminase concentra-
tions, whose values may reach several thousand 
units, hyperbilirubinemia, coagulopathy, he-
patic encephalopathy, hepatorenal syndrome 
and acute renal failure. The hepatorenal phase 
developed after 2-3 days and acute renal failure 
was registered on 3rd-5th day (13). The renal 
biopsy indicated acute massive necrosis of the 
proximal tubule (24). Multi-organ failure, dis-
seminated intravascular coagulation, seizures 
and death may occur one to three weeks after 
ingestion (16).
The diagnosis is made based on the combina-
tion of a history of consumption of wild mushrooms, 
prolonged latent period (over 6 hours), clinical data 
and increased liver enzymes. Patients were admitted 
for treatment most often at the end of the first day af-
ter the consumption of mushrooms (15-38), accord-
ing to our data - after 21 hours. The majority of these 
patients did not ask for medical assistance immedi-
ately after the appearance of the gastrointestinal syn-
drome because they did not associate the symptoms 
with mushroom consumption. This is the main rea-
son for the delay of the hospitalisation and compar-
atively late initiation of treatment. At the end of the 
first day after the mushrooms consumption liver en-
zymes are already increased several times the up-
per limit of the reference values and this facilitated 
the establishment of the correct diagnosis. There are 
difficulties in rare cases of coincidence between the 
consumption of wild non-poisonous (edible) mush-
rooms by patients with chronic liver diseases and 
complaints of vomiting and diarrhoea due to another 
reason - e.g. enterovirus infection that appeared af-
ter the sixth hour from the mushroom consumption. 
In these cases, the initial transaminase levels were 
abnormal, but not very high and we recommended 
retesting of hepatic transaminases after 3 hours, as 
their values should have been identical or very simi-
lar to the initially measured. In the case of A. phalloi-
des intoxication transaminase levels are significant-
ly increasing during this 3-hour interval. We adhere 
to this scheme, because radio-immunological and 
chromatographic determination of the amatoxins in 
serum or urine is not available for clinical practice in 
Bulgaria.
Active treatment starts immediately after the 
patient is hospitalized and the diagnosis is made. Se-
vere mushroom poisoning caused by amanitin re-
mains an unresolved problem in clinical toxicol-
ogy because no specific and fully efficient antidote 
is ready available (1,16,25). The recommended ther-
apeutic regimen in A. phalloides poisoning includes 
gastrointestinal decontamination procedures, rehy-
dration, correction of metabolic acidosis and elec-
trolyte abnormalities, specific therapies (silibinin, N-
acetylcystein, Penicillin G, MARS) and liver trans-
plantation (3,4,13,16,26,27,28). In Bulgaria, Silibinin, 









Table 2. Distribution of A. phalloides intoxication by 
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MARS and urgent liver transplantation were not 
available during this period. All patients hospitalised 
within 36 hours after consumption received extra-
corporeal treatment methods - hemodialysis hemo-
sorption or plasma filtration, although in the liter-
ature there is no convincing evidence of their effec-
tiveness (29,30). We applied hyperbaric oxygenation 
for faster regeneration of hepatocytes for all patients 
in the recovery stage. Our experience indicates that 
the protocol used in our Toxicology Unit is effective 
for amatoxin poisoning, because although not all rec-
ommended methods were available in Bulgaria the 
percentage of cured patients was as much as the aver-
age for Europe. A lethal outcome was registered in 25 
(17%) patients - 13 women and 12 men at the average 
age 56.8 years (26-85). The relative share of A. phal-
loides poisoning is 0.6% of all acute intoxications, but 
they cause 11.4% of lethality of acute poisonings. De-
spite the optimal treatment performed, lethality of 
A. phalloides intoxication is high and reaches 20% 
(3,22,31,32), or 30% in adults and 50% in children (4, 
8). A. phalloides mushrooms frequently cause acute 
liver failure, and sometimes acute renal failure and 
are associated with high lethality (2,33,34).
CONCLUSION
A. phalloides poisonings have a low frequency - 
0.8% of all intoxication, but are characterised by the 
development of life-threatening organ failures and 
high mortality - 17%. They cause 11.4% of lethality in 
acute intoxications. They are more common in men 
and the ratio of men to women is 1.62: 1. The share 
of patients over 45 years of age is 72.1%. A. phalloides 
intoxications in Bulgaria are mostly in late summer 
and autumn. A therapeutic option to reduce the high 
lethality is the implementation into clinical practice 
in Bulgaria of liver transplantation as a routine meth-
od in patients who develop acute liver failure when 
other treatment methods have proven ineffective.
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